Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
12/2010
12/29/2010WO2010149620A1 Polymerizable ambipolar hosts for phosphorescent guest emitters
12/29/2010WO2010149618A1 Polymeric ambipolar hosts for phosphorescent guest emitters
12/29/2010WO2010149541A1 Novel oxazolone and pyrrolidinone-substituted arylamides
12/29/2010WO2010149506A1 Insecticidal compounds
12/29/2010WO2010148650A1 5-membered heteroaryl derivatives used as sphingosine 1-phosphate receptor agonists
12/29/2010WO2010148649A1 5-membered heteroaryl derivatives used as sphingosine 1-phosphate receptor agonists
12/29/2010WO2010129848A3 2,6-dioxo-1,2,3,6-tetrahydropyrimidine-4-carboxamides
12/29/2010EP2266980A1 Polymorphic form of aprepitant intermediate
12/29/2010EP2266979A1 2-morpholino-4-pyrimidone compounds
12/29/2010EP2266977A1 2,4-di[(hetero)arylamino]-pyrimidine derivatives as zap-70 and/or syk inhibitors
12/29/2010EP2266969A2 6-(Pyridinyl)-4-pyrimidone derivatives as tau protein kinase 1 inhibitors
12/29/2010EP2266958A1 Antiviral agent
12/29/2010EP2265602A1 Substituted dihydropyrazolones as inhibitors of hif-prolyl-4-hydroxylases
12/29/2010EP2265601A1 Pyridazine derivatives as factor xia inhibitors
12/29/2010EP2265598A2 Novel hsp90 inhibitory carbazole derivatives, compositions containing same, and use thereof
12/29/2010EP2265594A2 Cysteine and cystine bioisosteres to treat schizophrenia and reduce drug cravings
12/29/2010EP2265592A1 Substituted pyraz inylmethyl sulfonamides for use as. fungicides
12/29/2010EP2265585A1 Amine and ether compounds which modulate the cb2 receptor
12/29/2010EP2265578A1 Azetidine derivatives
12/29/2010EP2265575A2 Sulfonamides
12/29/2010EP2265335A1 Indazole derivatives
12/29/2010EP2265273A1 Hexahydrocyclopentyl[f] indazole sulfonamides and derivatives thereof as selective glucocorticoid receptor modulators
12/29/2010EP2265270A1 2-aminopyridine kinase inhibitors
12/29/2010EP1861377B1 Benzimidazolone derivatives as cb2 receptor ligands
12/29/2010EP1809620B1 Novel tetrazole derivatives as positive allosteric modulators of metabotropic glutamate receptors
12/29/2010EP1791830B1 Diaminotriazole compounds useful as protein kinase inhibitors
12/29/2010EP1758578B1 Novel indazole carboxamides and their use
12/29/2010EP1530568B1 INDOLE OR BENZIMIDAZOLE DERIVATIVES FOR MODULATING I&kB KINASE
12/29/2010EP1292573B1 Substituted thioacetamides
12/29/2010CN1922139B Bicyclic amide derivatives
12/29/2010CN101932578A Gamma secretase modulators
12/29/2010CN101932577A Heteroaryl-substituted piperidines
12/29/2010CN101932576A Oxadiazole- and oxazole-substituted benzimidazole- and indole-derivatives as dgat1 inhibitors
12/29/2010CN101928284A Nitrogen-containing heterocyclic derivatives and drugs containing the same as the active ingredient
12/29/2010CN101503392B Aromatic aminomethane compounds, as well as preparation and medical use thereof
12/29/2010CN101468986B Method for splitting dihydropyrimidine racemic compound
12/29/2010CN101445504B Dioxane-2-alkyl carbamates derivatives
12/29/2010CN101142193B Propane-1,3-dion derivative or salt thereof
12/29/2010CN101113137B Intermidiate for preparing 1,2-oxygen nitrogen heterocyclic-2-alkene acylbenzene and its preparation
12/29/2010CA2766696A1 New compounds, pharmaceutical composition and methods relating thereto
12/29/2010CA2765823A1 Tricyclic heterocyclic compounds as mediators of p13k activity
12/29/2010CA2765819A1 Heterocyclic compounds and their uses as inhibitors of p13 k activity
12/29/2010CA2765692A1 Novel azabicyclohexanes
12/29/2010CA2765527A1 N-substituted-cyclic amino derivative
12/29/2010CA2764422A1 Insecticidal compounds
12/29/2010CA2754654A1 Novel oxazolone and pyrrolidinone-substituted arylamides
12/28/2010US7858794 such as 5-Chloro-thiophene-2-carboxylic acid (1-acetyl-7-dimethylamino-4-methyl-4-phenyl-1,2,3,4-tetrahydro-quinolin-6-yl)-amide, having follicle stimulating hormone modulatory activity, used to regulate fertility as contraceptives and for treatment of breast cancer, prostate cancer and endometriosis
12/28/2010US7858788 e.g. 9-Hydroxy-2-(2-methoxy-ethyl)-1,8-dioxo-1,8-dihydro-2H-pyrid[1,2-a]pyrazi ne-7-carboxylic acid 4-fluoro-banzylamide; Human T cell leukemia virus, Feline and Simian immunodeficiency virus inhibitor; side effects reduction
12/28/2010US7858782 e.g. N-(2-chloro-6-methylphenyl)-3-ethoxyacrylamide; protein (tyrosine and serine/threonine) kinase inhibitor; variety of conditions and diseases; antiproliferative, anticarcinogenic, antiinflammatory, antiallergenic agent; autoimmune and neurodegenerative disorders
12/28/2010US7858781 inflammatory conditions, allergies, autoimmune diseases, chronic pain, graft rejection, cancers which involve leukocyte filtration, stenosis or restenosis, atherosclerosis, rheumatoid arthritis, osteoarthritis; e.g. 4-Isobutoxy-1H-indole-2-carboxylic acid [4-(2-azepan-1-yl-ethyl)-phenyl]-amide
12/28/2010US7858649 Imidazole derivatives and their use for modulating the GABAA receptor complex
12/28/2010US7858645 Indazole derivatives
12/28/2010US7858633 Cycloalkyl substituted pyrimidinediamine compounds and their uses
12/28/2010US7858632 Purinergic receptor antagonists; genitourinary and pain-related diseases; for example, 5-(2-isopropyl-4,5-dimethoxybenzyl)-pyrimidine-2,4-diamine
12/28/2010US7858630 serotonin 5-HT2a and dopamine D3 receptors modulators such as N-trans-{4-[2-(4-benzo[d]isoxazol-3-yl)-piperazin-1-yl)-ethyl]-cyclohexyl}-3-methoxy-propionamide, useful in the treatment of cognitive disorders, drug addiction, depression, anxiety, dementia and psychological disorders
12/28/2010US7858629 3-{(3S)-4-{[1-(3-ethoxyphenyl)-2-(4-methylphenyl)-1H-imidazol-4-yl]carbonyl}-3 -[(isopropylamino)carbonyl]-1-piperazinyl}-1-naphthoic acid, useful for the treatment, control, or prevention of obesity and diabetes
12/28/2010US7858626 Pyrimidineamines as angiogenesis modulators
12/28/2010US7858623 Substituted amide derivatives and methods of use
12/28/2010US7858617 2-hexadecyloxy-6-methyl-4H-3,1-benzoxazin-4-one; inhibition of a lipase, esterase or phosphatase enzyme
12/28/2010US7858614 Therapeutic pyrazolonaphthyridine derivatives
12/28/2010US7858211 Organic electroluminescent device
12/23/2010WO2010147792A2 Compounds which selectively modulate the cb2 receptor
12/23/2010WO2010147791A1 Azetidine 2 -carboxamide derivatives which modulate the cb2 receptor
12/23/2010WO2010146881A1 Substituted isoquinoline derivative
12/23/2010WO2010146605A1 Novel gpr 119 agonists
12/23/2010WO2010146395A1 Pyrazine carboxamides as inhibitors of dgat1
12/23/2010WO2010146351A1 Indolylmethyl-morpholine derivatives as kinase inhibitors
12/23/2010WO2010146236A1 Urea substituted sulphonamide derivatives
12/23/2010WO2010146133A1 Heterocyclylaminopyrimidines as kinase inhibitors
12/23/2010WO2010146105A1 S1p1 agonists comprising a bicyclic n-containing ring
12/23/2010WO2010145992A1 Herbicidal benzoxazinones
12/23/2010WO2010145883A1 Novel substituted indazole and aza-indazole derivatives as gamma secretase modulators
12/23/2010WO2010145203A1 1,2,4-oxadiazol derivatives, their pharmaceutical compositions and their use as sphingosine 1-phosphate 1 receptor agonists
12/23/2010WO2010145201A1 Compounds
12/23/2010WO2010144959A1 Analogues of anti-fibrotic agents
12/23/2010WO2010091876A3 Small molecule bradykinin b1 receptor antagonists
12/23/2010US20100324295 Process for the production of substituted 5-quinolyl-oxazoles and pharmaceutically acceptable salts thereof
12/23/2010US20100324287 Process for phosphonic acid
12/23/2010US20100324284 Pyrrolopyrimidine derivative as p13k inhibitor and use thereof
12/23/2010US20100324104 1,2,3-triazoles as 11-beta hydroxysteroid dehydrogenase type i inhibitors
12/23/2010US20100324095 Pharmaceutical composition for inhibiting amyloid-beta protein accumulation
12/23/2010US20100324093 Ccr9 inhibitors and methods of use thereof
12/23/2010US20100324069 Oxazolone and pyrrolidinone-substituted arylamides as p2x3 and p2x2/3 antagonists
12/23/2010US20100324068 Chemical compounds 785
12/23/2010US20100324045 Cyclic urea inhibitors of 11beta-hydroxysteroid dehydrogenase 1
12/23/2010US20100324044 Metabotropic glutamate receptor isoxazole ligands and their use as potentiators
12/23/2010US20100324043 Bicyclic And Tricyclic Compounds As KAT II Inhibitors
12/23/2010US20100324042 Heterocyclic compounds and their use as glycogen synthase kinase 3 inhibitors
12/23/2010US20100324039 Substituted Indolealkanoic Acids
12/23/2010US20100324032 Compounds and uses thereof in modulating amyloid beta
12/23/2010US20100324030 5-Quinoline derivatives having an anti-bacterial activity
12/23/2010US20100324029 Therapeutic agents
12/23/2010US20100324025 Antibacterial Agents
12/23/2010US20100324017 Acylguanidine derivative
12/23/2010US20100324016 Heteroaromatic and aromatic piperazinyl azetidinyl amides as monoacylglycerol lipase inhibitors
12/23/2010US20100324015 Heteroaromatic and aromatic piperazinyl azetidinyl amides as monoacylglycerol lipase inhibitors
12/23/2010US20100324010 Amide compounds and use of the same
12/23/2010US20100324009 Substituted Sulfonamide Compounds
12/23/2010CA2765822A1 Novel gpr 119 agonists
12/23/2010CA2765525A1 Compounds which selectively modulate the cb2 receptor
1 ... 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 ... 647